QNTM
Quantum BioPharma Ltd.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.77M
P/E Ratio
—
EPS
$-8.20
Beta
0.29
52W High
$38.25
52W Low
$2.07
50-Day MA
$3.77
200-Day MA
$12.26
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. (QNTM) is an innovative biotechnology company focused on developing groundbreaking therapies for complex medical conditions, particularly in underserved areas such as oncology and autoimmune disorders. With a robust pipeline of advanced biopharmaceutical products, the company leverages cutting-edge technologies and a commitment to rigorous research and development. Quantum BioPharma’s strategic partnerships and a seasoned leadership team enhance its potential to capitalize on the growing demand for novel therapeutics, positioning it as a compelling investment opportunity within the dynamic biopharmaceutical landscape.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-14.76M |
| Operating Margin | 0.00% |
| Return on Equity | -346.90% |
| Return on Assets | -67.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.81 |
| Price-to-Book | 3.35 |
| Price-to-Sales (TTM) | 91.86 |
| EV/Revenue | 98.56 |
| EV/EBITDA | -1.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $5.83M |
| Float | $5.25M |
| % Insiders | 13.93% |
| % Institutions | 14.17% |
Data last updated: 4/9/2026